Butyrylcholinesterase levels and subjective effects of smoked cocaine in healthy cocaine users

References

• Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013. Avaiable from: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm [last accessed 9/8/2014]
   Google Scholar
• Zhan CG. Novel pharmacological approaches to treatment of drug overdose and addiction. Expert Rev Clin Pharmacol 2009;2:1–4
   Google Scholar
• Gorelick DA. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol Depend 1997;48:159–165
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 2012;122:3387–3393
   PubMed Web of Science ®Google Scholar
• Ciccarone D. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care 2011;38:41–58, v–vi
   PubMed Web of Science ®Google Scholar
• Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 2002;61:436–445
   Google Scholar
• Schindler AG, Messinger DI, Smith JS, Shankar H, Gustin RM, Schattauer SS, Lemos JC, et al. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci 2012;32:17582–17596
   PubMed Web of Science ®Google Scholar
• Schindler CW, Goldberg SR. Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity. Future Med Chem 2012;4:163–175
   PubMed Web of Science ®Google Scholar
• Zheng F, Zhan CG. Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications. Future Med Chem 2009;1:515–528
   Google Scholar
• Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003;4:131–138
   PubMed Web of Science ®Google Scholar
• Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989;260:625–634
   PubMed Web of Science ®Google Scholar
• Lynch TJ, Mattes CE, Singh A, Bradley RM, Brady RO, Dretchen KL. Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol Appl Pharmacol 1997;145:363–371
   PubMed Web of Science ®Google Scholar
• Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011;155:219–229
   PubMed Web of Science ®Google Scholar
• Gatley SJ. Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase. Biochem Pharmacol 1991;41:1249–1254
   PubMed Web of Science ®Google Scholar
• Devenyi P. Cocaine complications and pseudocholinesterase. Ann Intern Med 1989;110:167–168
   PubMed Web of Science ®Google Scholar
• Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 1992;21:247–253
   PubMed Web of Science ®Google Scholar
• Om A, Ellahham S, Ornato JP, Picone C, Theogaraj J, Corretjer GP, Vetrovec GW. Medical complications of cocaine: possible relationship to low plasma cholinesterase enzyme. Am Heart J 1993;125:1114–1117
   PubMed Web of Science ®Google Scholar
• Carmona GN, Schindler CW, Greig NH, Holloway HW, Jufer RA, Cone EJ, Gorelick DA. Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats. Eur J Pharmacol 2005;517:186–190
   PubMedGoogle Scholar
• Mattes CE, Lynch TJ, Singh A, Bradley RM, Kellaris PA, Brady RO, Dretchen KL. Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol Appl Pharmacol 1997;145:372–380
   PubMed Web of Science ®Google Scholar
• Narasimhan D, Woods JH, Sunahara RK. Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction. Future Med Chem 2012;4:137–150
   PubMed Web of Science ®Google Scholar
• Xue L, Ko MC, Tong M, Yang W, Hou S, Fang L, Liu J, et al. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Mol Pharmacol 2011;79:290–297
   Google Scholar
• Brimijoin S, Gao Y. Cocaine hydrolase gene therapy for cocaine abuse. Future Med Chem 2012;4:151–162
   PubMed Web of Science ®Google Scholar
• Anker JJ, Brimijoin S, Gao Y, Geng L, Zlebnik NE, Parks RJ, Carroll ME. Cocaine hydrolase encoded in viral vector blocks the reinstatement of cocaine seeking in rats for 6 months. Biol Psychiatry 2012;71:700–705
   PubMed Web of Science ®Google Scholar
• Kalapatapu RK, Bedi G, Haney M, Evans SM, Rubin E, Foltin RW. The subjective effects of cocaine: relationship to years of cocaine use and current age. Am J Drug Alcohol Abuse 2012;38:530–534
   PubMed Web of Science ®Google Scholar
• Haney M, Rubin E, Foltin RW. Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology (Berl) 2011;216:379–387
   PubMed Web of Science ®Google Scholar
• Vosburg SK, Haney M, Rubin E, Foltin RW. Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend 2010;110:144–150
   PubMed Web of Science ®Google Scholar
• Reed SC, Evans SM, Bedi G, Rubin E, Foltin RW. The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav 2011;59:227–235
   PubMed Web of Science ®Google Scholar
• Reed SC, Haney M, Evans SM, Vadhan NP, Rubin E, Foltin RW. Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend 2009;102:102–107
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr. Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95
   PubMed Web of Science ®Google Scholar
• Bablok W, Passing H, Bender R, Schneider B. A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem 1988;26:783–790
   PubMedGoogle Scholar
• Foltin RW, Fischman MW. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 1991;257:247–261
   PubMed Web of Science ®Google Scholar
• Foltin RW, Fischman MW. The relationship between cocaine venous blood levels and the cardiovascular and subjective effects of smoked and intravenous cocaine. NIDA Res Monogr 1990;105:440–441
   PubMedGoogle Scholar
• Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD. Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 1990;26:145–154
   PubMed Web of Science ®Google Scholar
• Foltin RW, Fischman MW. Residual effects of repeated cocaine smoking in humans. Drug Alcohol Depend 1997;47:117–124
   PubMed Web of Science ®Google Scholar
• Foltin RW, Ward AS, Haney M, Hart CL, Collins ED. The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend 2003;70:149–157
   PubMed Web of Science ®Google Scholar
• Alves-Amaral G, Pires-Oliveira M, Andrade-Lopes AL, Chiavegatti T, Godinho RO. Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: effects of sex hormone withdrawal. Chem Biol Interact 2010;186:9–15
   Google Scholar
• Zimmer KR, Lencina CL, Zimmer AR, Thiesen FV. Influence of physical exercise and gender on acetylcholinesterase and butyrylcholinesterase activity in human blood samples. Int J Environ Health Res 2012;22:279–286
   PubMed Web of Science ®Google Scholar
• Lane RM, He Y. Butyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotype. Alzheimers Dement 2013;9:e1–e73
   Google Scholar
• Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P. Increased CSF volumes are associated with diminished subjective responses to cocaine infusion. Neuropsychopharmacology 2000;23:468–473
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Bridge P, Mintz J. Cortical gray matter volumes are associated with subjective responses to cocaine infusion. Am J Addict 2004;13:64–73
   PubMed Web of Science ®Google Scholar
• Lundahl LH, Lukas SE. Negative cocaine effect expectancies are associated with subjective response to cocaine challenge in recreational cocaine users. Addict Behav 2007;32:1262–1271
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Sholar M, Mello NK, Teoh SK, Sholar JW. Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 1998;18:263–271
   PubMed Web of Science ®Google Scholar
• Mooney M, Sofuoglu M, Dudish-Poulsen S, Hatsukami DK. Preliminary observations of paranoia in a human laboratory study of cocaine. Addict Behav 2006;31:1245–1251
   PubMed Web of Science ®Google Scholar